Saturday, December 27, 2025
ADVT 
International

US risks losing talented H1-B visa holders to Canada: Study

Darpan News Desk IANS, 04 Nov, 2022 11:04 AM
  • US risks losing talented H1-B visa holders to Canada: Study

New Delhi, Nov 4 (IANS) The US risks losing talented foreigners, particularly those married to other skilled professionals, to Canada, which grants work authorisation to spouses of all skilled foreign workers, says a new study.

But granting employment authorisation to all spouses of H-1B visa holders would encourage more skilled migrants, including Indians, to choose the US over Canada, the study by National Foundation for American Policy revealed.

"The US can reap significant economic benefits, ease labour shortages, and attract more workers in the global competition for talent if it expanded current rules on work eligibility for the spouses of H-1B visa holders," the study, authored by Madeline Zavodny, said.

The number of Indians who became permanent residents in Canada increased by over 115 per cent between 2016 and 2020 and 2021.

In 2015, then President Barack Obama allowed the spouses of H-1B visa holders to work in the US via the H4 (dependent) visa.

H4 visas are issued to dependent spouses and children who accompany H-1B, H-2A, H-2B, and H-3 visa holders to the US.

The spouses of H-1B visa holders tend to be highly educated, many of them in STEM fields, and previously had careers of their own or worked to support their families.

"Allowing the spouses of H-1B visa holders to work upon arrival would help recruit and retain skilled workers and increase the already-considerable economic benefits of the H-1B visa category," Zavodny said.

She estimates that almost 90 per cent of the spouses of H-1B visa holders have at least a bachelor's degree, and over half have a graduate degree, based on American Community Survey data (2017-2019).

Out of these 90 per cent of spouses, two-thirds are from India and 6 per cent are from China.

"Almost half of spouses of likely H-1B visa holders who have a bachelor's degree had a STEM-related major. Among spouses of likely H-1B visa holders who are employed, 42 per cent are working in a STEM field," she noted.

The Department of Homeland Security (DHS) regulation published in 2015 allows spouses who hold an H4 visa to apply for an Employment Authorization Document (EAD).

Currently, H4 spouses can only apply for an EAD after their H-1B spouse is in the queue for a permanent visa.

That typically does not occur until the H-1B has worked in the US for several years; indeed, some spouses may apply only after their H-1B spouse has worked in the US for at least six years.

The H4 visa holder must be selected in the H-1B lottery, which only occurs once a year and has low odds of success.

Long delays in processing H4 EADs have plagued the US Citizenship and Immigration Services (USCIS) and the spouses who need the approval to work.

Spouses of workers who hold an L-1 intracompany transferee visa, an E-1 treaty trader, an E-2 treaty investor, or E-3 specialty occupation worker from Australia visa are allowed to work.

Spouses of these visa holders are "considered employment authorised incident to status", that is, their visa allows them to work and they do not need to apply separately for an EAD.

Since mid-2015, some 171,000 H-4 visa holders have been approved for employment authorisation, a significant portion of whom are from India.

In fiscal 2021, Indians bagged the highest number of H1B visas i.e., over 74 per cent of the allotments.

Out of 4.07 lakh H1-B visas approved by the USCIS, 3.01 lakh were allotted to Indians whereas, 50,000 Chinese received the visas.

Research shows that the H-1B visa category bumps up economic growth, creates jobs for American workers, and slows offshoring of high-paid jobs.

"If allowed to work, these spouses would make considerable contributions to the US labour market as most of them would enter occupations with very low unemployment rates and high job vacancy rates," says Zavodny.

Photo courtesy of IStock. 

MORE International ARTICLES

UK advises limiting AstraZeneca in under-30s amid clot worry

UK advises limiting AstraZeneca in under-30s amid clot worry
While the benefits of the vaccine still outweigh the risks, that assessment is “more finely balanced" among younger people who are less likely to become seriously ill with COVID-19

UK advises limiting AstraZeneca in under-30s amid clot worry

COVID vaccine found highly effective in real-world US study

COVID vaccine found highly effective in real-world US study
The two vaccines available since December — Pfizer and Moderna — were 90% effective after two doses, the Centers for Disease Control and Prevention reported Monday. In testing, the vaccines were about 95% effective in preventing COVID-19.

COVID vaccine found highly effective in real-world US study

Reputation of AstraZeneca's COVID vaccine marred by missteps

Reputation of AstraZeneca's COVID vaccine marred by missteps
In Norway, a top official warned on Monday it might not be able to resume its use of the vaccine because so many people were rejecting it.

Reputation of AstraZeneca's COVID vaccine marred by missteps

EXPLAINER: Will you need a 'vaccine passport' to travel?

EXPLAINER: Will you need a 'vaccine passport' to travel?
It is not clear, however, whether any of the passports under development will be accepted broadly around the world, and the result could be confusion among travellers and disappointment for the travel industry.

EXPLAINER: Will you need a 'vaccine passport' to travel?

EXPLAINER: Why Georgia attack spurs fears in Asian Americans

EXPLAINER: Why Georgia attack spurs fears in Asian Americans
As details emerge, many members of the Asian American community see the Georgia killings as a haunting reminder of harassment and assaults that have been occurring from coast to coast.

EXPLAINER: Why Georgia attack spurs fears in Asian Americans

EXPLAINER: Why countries are halting the AstraZeneca shot

EXPLAINER: Why countries are halting the AstraZeneca shot
Norway, Iceland, Bulgaria, Thailand, and Congo soon followed suit. On Saturday, Norwegian authorities reported that four people under age 50 who had gotten the AstraZeneca vaccine had an unusually low number of blood platelets.

EXPLAINER: Why countries are halting the AstraZeneca shot